Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-30

Clinical Trial Update: Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating second-line induction therapy plus a healthy diet for Ulcerative Colitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Miami | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2024-12-30